Danish industry unimpressed by medtech appraisal strategy
This article was originally published in Clinica
The Danish State Institute for Health Technology Assessment (MTV-Instituttet) strategy document for the years 2001-2003 has failed to impress the national industry association for medical devices. Ditte Norgaard-Andersen from the Danish Medical Device Association (DMDA) said: "I find it without vision - a lot of hot air. What we really need is a proper co-ordination of all national initiatives."
You may also be interested in...
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.